z-logo
open-access-imgOpen Access
Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia
Author(s) -
Olga Fedorenko,
A.J.M. Loonen,
F. Lang,
Valentina A. Toshchakova,
E.G. Boyarko,
A. Semke,
Н. А. Бохан,
Н. В. Говорин,
Lyubomir I. Aftanas,
Svetlana А. Ivanova
Publication year - 2014
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyu098
Subject(s) - tardive dyskinesia , dyskinesia , neurotoxicity , single nucleotide polymorphism , antipsychotic , medicine , schizophrenia (object oriented programming) , pharmacology , psychiatry , genetics , biology , gene , toxicity , genotype , parkinson's disease , disease
Tardive dyskinesia is a disorder characterized by involuntary muscle movements that occur as a complication of long-term treatment with antipsychotic drugs. It has been suggested to be related to a malfunctioning of the indirect pathway of the motor part of the cortical-striatal-thalamic-cortical circuit, which may be caused by oxidative stress-induced neurotoxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom